Immunic Therapeutics is a startup based in the United States, most recent round Series-c-plus, 4 tracked investors.
Immunic Therapeutics is a startup founded in 2012 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 4 investors associated with the company.
Immunic Therapeutics is a clinical-stage biotechnology company developing orally administered small-molecule therapies for chronic inflammatory, autoimmune and neurologic diseases, with programs targeting multiple sclerosis, celiac disease and other immune-mediated conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.